OncoResponse
2015
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Series B
LATEST DEAL TYPE
$6.7M
LATEST DEAL AMOUNT
16
INVESTORS
Description
Developer of therapeutic antibodies designed to provide care against immuno-oncology targets. The company's technology uses a proprietary B-cell technology platform to mine the immune system of cancer patients who have responded to cancer immunotherapy to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies to treat cancer. The company has several antibodies directed at modulating immunosuppression of the tumor microenvironment in pre-clinical development.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 1124 Columbia Street
- Suite 300
- Seattle, WA 98104
- United States
+1 (206) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore OncoResponse’s full profile, request a free trial.
OncoResponse Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series B) | 14-Jun-2019 | $6.7M | 000.00 | 000.00 | Completed | Pre-Clinical Trials |
| 3. Early Stage VC (Series B) | 01-Sep-2018 | 0000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 2. Early Stage VC (Series A) | 23-Mar-2017 | $29.5M | $29.5M | 000.00 | Completed | Generating Revenue |
| 1. Joint Venture | 06-Oct-2015 | Completed | Generating Revenue |
OncoResponse Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A | 00,000,000 | 00.000000 | 00.00 | 00 | 00 | 00 | 00 | 00.000 |
OncoResponse Competitors (25)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| UNUM Therapeutics | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 000000 - 000 | 00000 |
| 000000 00000000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 000000 - 000 | 00000 |
| 0000000 00000000 | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 000000 - 000 | 00000 |
| 0000 000000000000 | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 000000&0 | 00000 |
| 000000 00000000000 | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
OncoResponse Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 000000000 | 07-Nov-2017 | 000000000000000000 | Biotechnology | 00000000 000000 |
OncoResponse Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Qatar Investment Authority | Sovereign Wealth Fund | Minority | 000 0000 | 000000 0 | ||
| Redmile Group | Hedge Fund | Minority | 000 0000 | 000000 0 | ||
| Alexandria Real Estate Equities | Real Estate | Minority | 000 0000 | 000000 0 | ||
| Alexandria Venture Investments | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| ARCH Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 |
OncoResponse Executive Team (5)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Clifford Stocks | Co-Founder, Chief Executive Officer & Board Member | ||
| Kamal Puri | Chief Scientific Officer |
3 Former Executives
You’re viewing 2 of 5 executives. Get the full list »OncoResponse Board Members (8)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Andrew Perlman | GreatPoint Ventures | Board Member | 000 0000 | |
| Clifford Stocks | OncoResponse | Co-Founder, Chief Executive Officer & Board Member | 000 0000 | |
| John McKearn Ph.D | RiverVest Venture Partners | Board Member | 000 0000 | |
| Nathan Jorgensen | Self | Board Member | 000 0000 | |
| Roberto DePonti | Helsinn Healthcare | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 5 of 8 board members. Get the full list »